[Elsevier] Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial |
|
This post will be closed automatically in 2026-10-26 12:57
Reward10points
|
| |
post
reply
points
90
10
Dual-ligand functionalized pH- and thermo-sensitive niosomes for precise targeted therapy and imaging of HER-2-positive breast cancer
50
Food Packaging and Preservation
10
P2.160: Dynamic Changes in Therapeutic Target Protein Expression in Non-Small Cell Lung Cancer by Actionable Gene Alteration Status
10
Plant-derived peptides and their emerging applications in agricultural biotechnology
10
In silico prediction and mass spectrometric characterization of botanical antimicrobial peptides
